Literature DB >> 851131

Drug administration in renal failure.

J S Cheigh.   

Abstract

Renal failure impairs urinary excretion of drugs and may also modify drug action by alternations in protein binding, distribution, biotransformation and, possibly, by retention of active metabolites. Dialysis adds another variable by altering the blood levels of those drugs soluble in plasma water and therefore available for diffusion or ultrafiltration. Renal insufficiency clearly modifies decisions about the choice and dose of a wide variety of drugs. Although data are accumulating at a rapid rate, available information about the use of drugs in patients with kidney disease is rather limited. The following is a summary of recent information on the use of a variety of drugs frequently utilized in patients with impaired renal function. The guidelines presented here are not absolute, but they are intended to be practical and reasonable, based on current information for adult patients of average size with kidney disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 851131     DOI: 10.1016/0002-9343(77)90418-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

1.  Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency.

Authors:  R Verbeeck; T B Tjandramaga; A Mullie; R Verbesselt; R Verberckmoes; P J de Schepper
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

2.  Digoxin-quinidine interaction in patients with renal failure.

Authors:  R Hirschberg; K Schaefer; D von Herrath; G Kreutz; H Kewitz
Journal:  Klin Wochenschr       Date:  1981-05-15

3.  Pharmacokinetics of dihydroquinidine in congestive heart failure patients after intravenous quinidine administration.

Authors:  C T Ueda; B S Dzindzio
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

4.  Dihydrocodeine in renal failure: further evidence for an important role of the kidney in the handling of opioid drugs.

Authors:  J N Barnes; A J Williams; M J Tomson; P A Toseland; F J Goodwin
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.